[Current aspects of immunomodulatory therapy initiation for sepsis]

Dtsch Med Wochenschr. 1998 Jul 31;123(31-32):948-52. doi: 10.1055/s-2007-1024103.

[Article in German]

Authors

W Karzai¹, H J Gramm, K Reinhart

Affiliation

¹ Klinik für Anästhesiologie und Intensivtherapie, Klinikum der Friedrich-Schiller-Universität, Jena.

PMID: 9721572
DOI: 10.1055/s-2007-1024103

No abstract available

Publication types

Review

MeSH terms

Adjuvants, Immunologic / therapeutic use*
Anti-Inflammatory Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Granulocyte Colony-Stimulating Factor / therapeutic use
Humans
Immunization, Passive
Interleukin-1 / therapeutic use
Platelet Activating Factor / antagonists & inhibitors
Sepsis / etiology
Sepsis / therapy*
Steroids
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Adjuvants, Immunologic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Interleukin-1
Platelet Activating Factor
Steroids
Tumor Necrosis Factor-alpha
Granulocyte Colony-Stimulating Factor